A case report of endorectal displacement of a right ureteral stent following radiochemotherapy and Bevacizumab
The angiogenesis inhibitor monoclonal antibody Bevacizumab is presently the standard treatment for numerous neoplasms but particular toxicities are emerging, such as hypertension, haemorrhage, thromboembolism,...
Source: BMC Urology - Category: Urology & Nephrology Authors: Alessio Tognarelli, Lorenzo Faggioni, Francesca Manassero, Angiolo Gadducci and Cesare Selli Tags: Case report Source Type: research
More News: Avastin | Hypertension | Thrombosis | Toxicology | Ureter and Renal Pelvis Cancer | Urology & Nephrology